Omega Therapeutics, Inc.
NASDAQ:OMGA
0.86 (USD) • At close January 7, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | Omega Therapeutics, Inc. |
Symbool | OMGA |
Munteenheid | USD |
Prijs | 0.858 |
Beurswaarde | 47,515,273 |
Dividendpercentage | 0% |
52-weken bereik | 0.74 - 5.07 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Mahesh Karande |
Website | https://www.omegatherapeutics.com |
An error occurred while fetching data.
Over Omega Therapeutics, Inc.
Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-regulate the expression of HNF4a,
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)